The job losses at biotech firm Merck Serono were part of a wider restructuring plan “to create a leaner, more agile organisation,” the company said in a statement.
“The planned measures for Merck Serono’s operations in Switzerland are needed to ensure our global competitive position in a rapidly changing market and to secure the long-term future of the company,” said Stefan Oschmann, head of the Serono division.
“Regrettably, these planned measures include the closure of our headquarters in Geneva, which would result in workforce reductions and the redeployment of certain Switzerland-based functions to other Merck locations,” he added.
The company said it planned to start retrenchments and relocations in the second half of 2012, and complete the closure of the Geneva operation in the first half of 2013.
Merck Serono will now operate out of a single campus in Darmstadt, Germany, to eliminate “duplications of functions” at two European headquarters, Merck said.
Source:
Read More @ Merck pharma closes Swiss HQ, cuts 580 jobs – The Local.
Job Market Monitor 
Discussion
Trackbacks/Pingbacks
Pingback: Actelion Plans – 135 Jobs cut « Job Market Monitor - July 12, 2012
Pingback: Merck / To cut 8,500 jobs | Job Market Monitor - October 1, 2013
Pingback: Novartis / To Cut 500 Jobs | Job Market Monitor - November 7, 2013